We are excited to announce the appointment of a new Director of our Research Centre, Professor Iain McNeish.
Iain is currently Professor of Gynaecological Oncology at the University of Glasgow and brings 25 years of scientific and clinical expertise to the role. He will take up his position as Imperial’s new Chair of Oncology in the Division of Cancer on 1st November.
Iain says, “I’m delighted about the new role and eager to get started. The Ovarian Cancer Action Research Centre has an excellent reputation and I want to build on the successes of the team who are working hard to find new treatments for ovarian cancer.”
Our Chair and Founder, Allyson Kaye, responded to the appointment saying: “I’m thrilled to welcome Iain. He is an outstanding scientist with an international reputation in ovarian cancer research, who we’ve worked with closely for more than a decade.”
Fomer Director, Professor Hani Gabra, is taking up a new role at pharmaceutical company AstraZeneca and we would like to thank him for his important contribution to ovarian cancer research and leadership of the Ovarian Cancer Action Research Centre since its inception in 2006.
Under Hani’s directorship, the Centre – a collaboration between OCA, Imperial College London, Imperial College Healthcare NHS Trust, the Institute of Cancer Research and the Royal Marsden Hospital – gained an international reputation for excellence in ovarian cancer research.
Chief Executive, Katherine Taylor, says: “We’re excited about the next phase of research under Iain’s directorship and we would like to thank our wonderful supporters for making this work possible. Together we will nail this disease once and for all.”